Multiplex Testing allows for easy scanning of population during Flu Seasons to differentiate between COVID and FLU patients and allow efficient scaling for clinics, professionals, employers and hospitals worldwide.
As compared to antibody or nucleic acid methods, antigen based diagnostic test can efficiently detect the multiple viruses in the incubation period in single test.
RapigenesTM is partnering with leaders in the industry to develop an antigen based multiplex test that detects the antigens of Covid-19/MERS-CoV/Influenza virus A/Bs in a single test.